Hospital Univ Doce de Octubre

Madrid 28041

1 studies enrolling now · 1 studies all time

What they study most

Non Small Cell Lung Cancer, ROS1-positive Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors — Available (expanded access)